{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T12:39:56Z","timestamp":1705322396296},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care & Pain Medicine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.accpm.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T01:01:15Z","timestamp":1434416475000},"page":"141-144","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to \u03b2-lactams in ICU patients: A pilot study"],"prefix":"10.1016","volume":"34","author":[{"given":"Herv\u00e9","family":"Dupont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Zogheib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedi","family":"Mammeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Friggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nacim","family":"Ammenouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Levrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norair","family":"Airapetian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Tinturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazine","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2015.02.004_bib0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.accpm.2015.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jac\/dkm076","article-title":"Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study","volume":"59","author":"Cavallo","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0015","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/pro.612","article-title":"Exploring sequence requirements for C(3)\/C(4) carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: insights into plasticity of the AmpC beta-lactamase","volume":"20","author":"Drawz","year":"2011","journal-title":"Protein Sci"},{"key":"10.1016\/j.accpm.2015.02.004_bib0020","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.42.7.1610","article-title":"Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa","volume":"42","author":"Lister","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0025","doi-asserted-by":"crossref","first-page":"29057","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new simplified acute physiology score (SAPS II) based on a European-North American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2015.02.004_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2015.02.004_bib0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","article-title":"Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic \u201cblind\u201d broncho-alveolar lavage fluid","volume":"143","author":"Pugin","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.accpm.2015.02.004_bib0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dki303","article-title":"Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test","volume":"56","author":"Vedel","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajic.2011.05.020","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary of 36\u00a0countries, for 2004\u20132009","volume":"40","author":"Rosenthal","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.accpm.2015.02.004_bib0050","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1128\/AAC.48.12.4606-4610.2004","article-title":"National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002","volume":"48","author":"Obritsch","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0055","first-page":"358","article-title":"Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea","volume":"45","author":"Lee","year":"2007","journal-title":"J Microbiol"},{"key":"10.1016\/j.accpm.2015.02.004_bib0060","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.accpm.2015.02.004_bib0065","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/jac\/dkr290","article-title":"Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007\u201309","volume":"66","author":"Davies","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/AAC.01645-10","article-title":"Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study","volume":"55","author":"Cabot","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0075","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.01410-08","article-title":"Extended-spectrum cephalosporinases in Pseudomonas aeruginosa","volume":"53","author":"Rodriguez-Martinez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2015.02.004_bib0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.diagmicrobio.2008.11.007","article-title":"Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia","volume":"63","author":"Tam","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.accpm.2015.02.004_bib0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2005.01.011","article-title":"Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin\/sulbactam against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp","volume":"25","author":"Sader","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2015.02.004_bib0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2012.06.004","article-title":"Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?","volume":"40","author":"Harris","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2015.02.004_bib0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0732-8893(03)00158-5","article-title":"Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and \u03b2-lactams tested against Gram-negative bacilli","volume":"47","author":"Sader","year":"2003","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Anaesthesia Critical Care & Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556815000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556815000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T21:29:33Z","timestamp":1566854973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556815000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2352556815000533"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2015.02.004","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to \u03b2-lactams in ICU patients: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}